This content is restricted.
Debate with AI #13 – Disease most closely linked to host–microbiome interactions
Debate with AI
Debate #13
Which of the following is the best example of a disease caused by interactions between the host and its microbiome, rather than by a specific pathogen?
First, vote based on your clinical judgement. Then see how the artificial intelligence answers. And finally, debate with the community.
1
Step 1
Vote before watching the video
Voting unlocks the AI’s answer.
2
Step 2
This is what the AI says
Vote first to see the AI’s answer
This way you can compare your judgement with the AI agent’s reasoning without being influenced.
AInflammatory bowel disease, due to an imbalance in the microbiota, disruption of the intestinal barrier, and a dysfunctional immune response.
The expert
Adrián Mosquera Orgueira
Specialist in Hematology and Hemotherapy
Hematologist at the University Hospital of Santiago de Compostela and Doctor of Medicine from the University of Santiago de Compostela. He leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), which focuses on applying genomics and artificial intelligence to precision medicine, with the aim of better predicting how hematological cancers respond to treatment and developing personalised therapies.
He has co-authored dozens of research papers published in high-impact journals such as Leukemia, Blood Cancer Journal, HemaSphere and Cancers, and combines research with his clinical work at CHUS and science communication.
Step 3 · Debate
Write a comment
Do you agree with the AI?
Share your point of view, your nuances and your clinical experience. This is where the community goes further than any automated answer.
Podcast S3E7 – EN
This content is restricted.
Adrián Mosquera Recognized at the Fundación ASISA Awards
Adrián Mosquera recognized at the Fundación ASISA Awards
The project led by Adrián Mosquera has been selected in the first edition of the Fundación ASISA Awards for Health Research and Social Projects.
The project led by Adrián Mosquera, founder of Código Rojo and a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela, has been recognized in the first edition of the Fundación ASISA Awards for Health Research and Social Projects.
The initiative, focused on artificial intelligence applied to clinical knowledge in oncohematology, has been selected as one of the five health research projects recognized in this first edition. The award includes a €6,000 grant to support the development of the project.
The project
The research aims to validate an artificial intelligence tool designed to facilitate safer access to clinical knowledge, as part of a research line combining artificial intelligence, genomics and precision medicine.
Adrián Mosquera conducts his research within the Computational Hematology and Genomics Group (GrHeco-Xen) at the Health Research Institute of Santiago (IDIS), while also combining his research work with clinical practice and scientific communication.
At Código Rojo, we are pleased to celebrate this recognition and the support it provides for continued research into the applications of artificial intelligence in healthcare.
The researcher
Adrián Mosquera Orgueira
Founder of Código Rojo · Hematology and Hemotherapy
Meet Adrián
Moments from the ceremony
We share some moments from the Fundación ASISA Awards ceremony.
Get to know the project from the inside
Listen to the specialists who make Código Rojo possible and discover how we work to bring artificial intelligence into clinical practice safely.
Podcast S3E6 – EN
This content is restricted.
Podcast S3E5 – EN
This content is restricted.
Podcast S3P3 – EN
This content is restricted.
Debate with AI #12 – Most beneficial non-pharmacological intervention for health
debate con la IA
Antes de ver el vídeo, vota:
The Expert
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.
Podcast S3P2 – EN
This content is restricted.
Debate with AI #11 – Three high-value measures in a healthcare system
Debate with AI
Before watching the video, vote:
The Expert
Adrián Mosquera Orgueira is a specialist in Hematology and Hemotherapy at the University Hospital of Santiago de Compostela and holds a Doctorate in Medicine from the University of Santiago de Compostela. He currently leads the Computational Hematology and Genomics Group (GrHeco-Xen) at the Santiago Health Research Institute (IDIS), focusing on the applications of genomics and artificial intelligence in the field of precision medicine. This line aims to improve the prediction of hematological cancer response to available treatments, as well as the development of personalized therapies for hematological cancer. He is the co-author of dozens of research papers in recent years, including publications in high-impact journals in the Hematology sector such as Leukemia, Blood Cancer Journal, Hemasphere, and Cancers. Additionally, he is currently involved in several research projects in the field of various hematological neoplasms. Dr. Mosquera combines this research activity with his clinical practice at CHUS and with the dissemination of scientific knowledge.